Ichiro Onoyama
Papers
1
Total Citations
7
H-Index
1
About
Ichiro Onoyama is a leading figure in gynecologic oncology, with a focused research program on the intersection of minimally invasive surgery and metabolic health in endometrial cancer. His work critically examines how the rising prevalence of obesity—a key driver of endometrial cancer—impacts surgical outcomes. In his landmark 2022 study, Onoyama provided pivotal evidence that robotic-assisted surgery is both safe and effective for patients with stage IA endometrial cancer, even among those who are morbidly obese. By comparing clinical outcomes across nonobese, obese, and morbidly obese cohorts, he demonstrated that robotic techniques can overcome the traditional surgical risks associated with high BMI, such as longer operative times and increased complications. This contribution, which has already garnered 7 citations, is reshaping clinical guidelines and expanding surgical access for a growing patient population. Onoyama’s work is notable for its direct clinical translation, offering surgeons a data-driven rationale to adopt robotic approaches without compromising oncologic safety. His research continues to influence how surgical teams tailor treatment for low-risk endometrial cancer, making him a key voice in the modernization of gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1